«Our study aimed to compare contrast - enhanced mammography with breast MRI in evaluating residual breast cancer in patients undergoing
presurgical systemic treatment to shrink their tumor size,» says Bhavika Patel, M.D., a radiologist at Mayo Clinic's Arizona campus.